Proxy Vote Update: Dr. Reddy’s Laboratories
rF Voting Results:
1. To receive, consider and adopt the Audited Financial Statements (Standalone and Consolidated) of the Company for the financial year ended March 31, 2025, together with the Reports of the Board of Directors and Auditors thereon. – FOR
2. To declare dividend of Rs. 8/- per equity share for the financial year ended March 31, 2025. – FOR
3. To re-appoint Mr. G V Prasad (DIN:00057433), as a Director, who retires by rotation, and being eligible offers himself for re-appointment.– AGAINST
4. To approve the re-appointment of Mr. G V Prasad (DIN:00057433) as Whole-Time Director designed as Co-Chairman and Managing Director. – AGAINST
5. Ratification of remuneration payable to Cost Auditors, M/s. Sagar & Associates, Cost Accountant for the financial year ending March 31, 2026.– FOR
6. To approve appointment of M/s. Makarand M. Joshi & Co., Company Secretaries as Secretarial Auditor of the company. – FOR
This article was written for information purposes only and its content should not be construed by any consumer and/or prospective client as rebel Financial’s solicitation to affect, or attempt to affect transactions in securities, or the rendering of personalized investment advice for compensation. No client or prospective client should assume that any such discussion serves as the receipt of, or a substitute for, personalized advice from rebel Financial, or from any other investment professional. See our disclosures page for more information.
Facebook
Twitter
LinkedIn
Email
Phil Ratcliff
Phil Ratcliff, President of rebel Financial, is a senior financial advisor that holds an AIF®, CFP®, ChFC®, and CLU® certifications. He started his career at American Express Financial Advisors in 2003, then moved to AXA Advisors for 7 years before founding rebel Financial LLC in 2013.